Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 4 2Phase 2 2Phase 1/2 2Phase NA 1Phase 2/3 1

Status

Completed 515Terminated 132Unknown 123Recruiting 117Active not recruiting 64Withdrawn 51Not yet recruiting 44Suspended 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 1

Conditions

Colorectal Neoplasms 6Stomach Neoplasms 5Melanoma 5Carcinoma, Non-Small-Cell Lung 5Neoplasm Metastasis 4Leukemia, Myeloid, Acute 4Glioblastoma 4Breast Neoplasms 4Prostatic Neoplasms 3Pancreatic Neoplasms 3Neoplasms 3Glioma 3Carcinoma, Renal Cell 3Uterine Cervical Neoplasms 2Sarcoma 2Rectal Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Osteosarcoma 2Nasopharyngeal Carcinoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Mesothelioma, Malignant 2Lymphoma 2Lung Neoplasms 2Leukemia, Lymphocytic, Chronic, B-Cell 2Diffuse Intrinsic Pontine Glioma 2Warts 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1

Interventions

Docetaxel 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Suspended × Lung Neoplasms × Clear all
NCT01723306 2016-06-14

Phase II/Pilot Study of 2nd Generation Anti-CEA Designer T Cells in Adenocarcinomas

Roger Williams Medical Center

Phase 2 Suspended
48 enrolled
GastrointestinalThoracic

Lung Neoplasms, Neoplasms, Stomach Neoplasms, Colorectal Neoplasms

NCT01356303 2016-05-13

TAXIS01

National Guard Health Affairs

Phase 2 Suspended
50 enrolled
Thoracic

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡